RHONDA WILSON: Open Payments
NPI 1780162610 · SWAINSBORO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,098 in 107 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $494 · 2025 $2,098
Food & beverage: $2,098
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 16 | $338 |
| ABBVIE INC. | 16 | $315 |
| Axsome Therapeutics, Inc. | 13 | $276 |
| Alkermes, Inc. | 15 | $207 |
| Vanda Pharmaceuticals Inc. | 9 | $192 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $188 |
| Tris Pharma Inc | 5 | $105 |
| Janssen Pharmaceuticals, Inc | 4 | $77 |
| Corium, LLC | 4 | $70 |
| Teva Pharmaceuticals USA, Inc. | 4 | $65 |
Products named: INGREZZA, VRAYLAR, Auvelity, ARISTADA, FANAPT, CAPLYTA, Dyanavel XR, REXULTI.
Industry payments across GA — which companies pay providers there.
